申请人:Mevellec Franck
公开号:US20050008568A1
公开(公告)日:2005-01-13
The invention relates to a technetium or rhenium complex of formula (I):
[M (R
1
CS
3
)
2
L] (I)
in which M is Tc or Re, R
1
represents an alkyl, cycloalkyl, aralkyl or aryl group which is unsubstituted or substituted by one or more substituents chosen from halogen atoms, the hydroxyl group, alkyl groups and alkoxy groups, and L is a dithiolate ligand, with the exception of the ligand of formula R
2
CS
2
in which R
2
is identical to R
1
.
The dithiolate ligand is preferably a dithiocarbamate.
The invention also relates to a radiopharmaceutical product comprising a complex of formula (I) with M representing
99
Tc,
186
Re or
188
Re.
该发明涉及公式(I)的锝或铼配合物:
[M(R
1
CS
3
)
2
L] (I)
其中M为Tc或Re,R
1
代表未取代或取代为一个或多个卤素原子、羟基、烷基和烷氧基中的一种取代基的烷基、环烷基、芳基或芳基,L为二硫醚配体,但不包括公式R
2
CS
2
中R
2
与R
1
相同的配体。
该二硫醚配体优选为二硫代氨基甲酸酯。
该发明还涉及包含公式(I)中M代表
99
Tc、
186
Re或
188
Re的放射性药物产品。